Safety, Effectiveness, and Tolerability of Patiromer in Kidney Transplant Recipients

Transplantation. 2019 Sep;103(9):e281-e282. doi: 10.1097/TP.0000000000002829.
No abstract available

Publication types

  • Letter

MeSH terms

  • Biomarkers / blood
  • Chelating Agents / adverse effects
  • Chelating Agents / therapeutic use*
  • Drug Interactions
  • Humans
  • Hyperkalemia / blood
  • Hyperkalemia / diagnosis
  • Hyperkalemia / drug therapy*
  • Hyperkalemia / etiology
  • Immunosuppressive Agents / blood
  • Immunosuppressive Agents / therapeutic use
  • Kidney Transplantation / adverse effects*
  • Patient Safety
  • Polymers / adverse effects
  • Polymers / therapeutic use*
  • Potassium / blood*
  • Retrospective Studies
  • Risk Assessment
  • Tacrolimus / blood
  • Tacrolimus / therapeutic use
  • Treatment Outcome

Substances

  • Biomarkers
  • Chelating Agents
  • Immunosuppressive Agents
  • Polymers
  • patiromer
  • Potassium
  • Tacrolimus